Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 11.97 Delayed Data As of Jan 15 |  +0.47 / +4.09%Today’s Change | 6.25 Today|||52-Week Range 13.76 | +24.04% Year-to-Date |
Latest TEVA News | Press Releases
| 3 Turnaround Stocks That Will Make You Richer in 2021 6:06am / MotleyFool.com - Paid Partner Content | Biohaven (BHVN) Initiates Pivotal Study on OCD Candidate Jan 05 / Zacks.com - Paid Partner Content |
| 5 Value Stocks That Will Make You Richer in 2021 Jan 09 / MotleyFool.com - Paid Partner Content | 8 Stocks That Could Double Your Money in 2021 Jan 04 / MotleyFool.com - Paid Partner Content |
| 5 Buffett Stocks to Buy Hand Over Fist in 2021 Jan 06 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 11.50 |
| Today’s open | 11.69 |
| Day’s range | 11.51 - 12.05 |
| Volume | 12,430,477 |
| Average volume (3 months) | 8,238,360 |
| Market cap | $12.9B |
Data as of 3:59pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +60.78% |
| Earnings growth (this year) | +4.75% |
| Earnings growth (next 5 years) | +4.31% |
| Revenue growth (last year) | -9.92% |
| P/E ratio | NM |
| Price/Sales | 0.63 |
| Price/Book | 0.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | -1.14 | -1.63% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
| BGNEBeigene Ltd | +8.99 | +2.68% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | February 10, 2021 |
| EPS forecast (this quarter) | $0.63 |
| Annual revenue (last year) | $16.9B |
| Annual profit (last year) | -$1.0B |
| Net profit margin | -5.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
